Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7 T MRI

Neurology

Volumn 81, Issue 6, 2013, Pages 534-540

  Blazejewska, Anna I ^a   Schwarz, Stefan T ^a   Pitiot, Alain ^a   Stephenson, Mary C ^a   Lowe, James ^b   Bajaj, Nin ^b   Bowtell, Richard W ^a   Auer, Dorothee P ^a   Gowland, Penny A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; NERVE PROTEIN; NEUROMELANIN; NIGROSOME 1; UNCLASSIFIED DRUG;

ARTICLE; CEREBRAL PEDUNCLE; CONTROLLED STUDY; DISEASE DURATION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL NOISE RATIO; SUBSTANTIA NIGRA PARS COMPACTA;

ADULT; AGED; CALBINDINS; DOPAMINE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MELANINS; MIDDLE AGED; PARKINSON DISEASE; S100 CALCIUM BINDING PROTEIN G; SUBSTANTIA NIGRA;

EID: 84884574164     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829e6fd2     Document Type: Article

References (31)

1. Lehéricy S, Sharman MA, Santos CLD, Paquin R, Gallea C. Magnetic resonance imaging of the substantia nigra in Parkinson's disease. Mov Disord 2012;27:822-830.
2. Auer DP. In vivo imaging markers of neurodegeneration of the substantia nigra. Exp Gerontol 2009;44:4-9.
3. Massey LA, Yousry TA. Anatomy of the substantia nigra and subthalamic nucleus on MR imaging. Neuroimaging Clin N Am 2010;20:7-27.
4. Haines DE. Fundamental Neuroscience for Basic and Clinical Applications. Philadelphia: Churchill Livingstone Elsevier; 2006.
5. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain I: nigrosomes and the nigral matrix, a compartmental organization based on calbindin D 28K immunohistochemistry. Brain 1999;122: 1421-1436.
6. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain II: patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122:1437-1448.
7. Baron S,Wood D. Rec. 601-the origins of the 4:2:2 DTV standard. In: EBU Technical Review. Grand-Saconnex, Switzerland: European Broadcasting Union; 2005:1-11.
8. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001;23:291-299.
9. Sasaki M, Shibata E, Kudo K, Tohyama K. Neuromelanin-sensitive MRI. Clin Neuroradiol 2008;18:147-153.
10. Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Move Disord 2011;26:1633-1638.
11. Huges AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;5:181-184.
12. Kwon DH, Kim JM, Oh SH, et al. Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol 2012;71:267-277.
13. Berg D. Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease. J Neural Transm 2011;118:453-461.
14. Griffiths PD, Dobson BR, Jones GR, Clarke DT. Iron in the basal ganglia in Parkinson's disease: an in vitro study using extended X-ray absorption fine structure and cryoelectron microscopy. Brain 1999;122:667-673.
15. Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 1988;74: 199-205.
16. Friedman A, Galazka-Friedman J, Koziorowski D. Iron as a cause of Parkinson disease: a myth or a well established hypothesis? Parkinsonism Relat Disord 2009;15(suppl 3): 212-214.
17. Haacke EM, Cheng NYC, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25.
18. Minati L, Grisoli M, Carella F, Simone TD, Bruzzone MG, Savoiardo M. Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery. AJNR Am J Neuroradiol 2007;28:309-313.
19. Lotfipour AK, Wharton S, Schwarz ST, et al. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging 2012; 35:48-55.
20. Gore JC, Kang YS, Schulz RJ. Measurement of radiation dose distributions by nuclear magnetic resonance (NMR) imaging. Phys Med Biol 1984;29:1189-1197.
21. Scharg M, Dickson A, Jiffry A, Kirsch D, Vinters HV, Kirsh W. The effect of formalin fixation on the levels of brain transition metals in archived samples. Biometals 2010;23:1123-1127.
22. Gellein K, Flaten TP, Erikson KM, Aschner M, Syversen T. Leaching of trace elements from biological tissue by formalin fixation. Biol Trace Elem Res 2008;121:221-225.
23. Maclaren J, Lee KJ, Luengviriya C, Speck O, Zaitsev M. Combined prospective and retrospective motion correction to relax navigator requirements. Magn Reson Med 2011;65:1724-1732.
24. Ordidge RJ, Gorell JM, Deniau JC, Knight RA, Helpern JA. Assessment of relative brain iron concentrations using T2-weighted and T2-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335-341.
25. Cho Z, Kim Y, Han J, et al. New brain atlas: mapping the human brain in vivo with 7.0 T MRI and comparison with Postmortem histology: will these images change modern medicine? Int J Imaging Syst Technol 2008;18:2-8.
26. Cho Z, Oh S, Kim J. Direct Visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging. Move Disord 2011;26:713-755.
27. Menke RA, Scholz J, Miller KL, et al. MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 2009;47: 435-441.
28. Menke RA, Jbabdi S, Miller KL, Matthews PM, Zarei M. Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage 2010;52:1175-1180.
29. Eapen M, Zald DH, Gatenby JC, Ding Z, Gore JC. Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain. AJNR Am J Neuroradiol 2011;32: 688-694.
30. Mai JK, George P. The Human Nervous System, 2nd ed. Philadelphia: Elsevier; 2004.
31. Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134: 3602-3615.